Led · Equity · Apr 2025

Catchfree develops plant-based seafood products using rice, soy protein and algae. Its product portfolio includes shrimp, fish burgers and fish bites. The company emerged from the Swiss Federal Institute of Technology (ETH) and is led by Severin Eder and Eduard Muller. Based in Zurich, Switzerland, Catchfree recently raised $1.5M to support its next phase. The company intends to use the funds to expand development efforts and scale production capacity. Catchfree is focused on advancing product development and increasing manufacturing to bring its plant-based seafood to market.

Participated · Series C · Jan 2025

Meteomatics aggregates weather data from more than 110 sources and its own autonomous weather drones, normalizing it into a single API product for enterprise customers. The platform refreshes forecasts hourly and delivers precision predictions down to one square kilometer. Customers can consume the unified data directly or run their own analytics and AI on top of the API. The company serves more than 600 customers, including Tesla, CVS Health, and Swiss Re. Founded in 2012 and based in St. Gallen, Switzerland, Meteomatics has largely reinvested its profits over a 12-year history to avoid frequent fundraising. The startup plans further product and tech development alongside geographic expansion into the U.S. Meteomatics runs a 1 km-resolution weather model that updates hourly to deliver hyperlocal forecasts and identify small-scale meteorological phenomena such as thunder, hail and wind. The company augments its models with data from its Meteodrones—weather drones that can fly up to 6 km (20,000 feet)—and 110 other sources to provide mid- and lower-atmosphere forecasting. Led by Founder and CEO Dr. Martin Fengler, Meteomatics serves more than 450 companies, including CVS Health, Tesla, Swiss Re, Airbus, Toyota, Volkswagen and EDF Energy. Customers use its data for energy optimization, logistics, process automation, risk management and product design. The company is headquartered in St. Gallen, Switzerland, with local U.S. operations in Pennsylvania. Meteomatics says it will use recent funding to scale its high-resolution weather and climate technology and expand into new markets and industries. Meteomatics is a Swiss-based company that provides real-time, granular and accurate weather forecast data via a proprietary in-house technology and API. The firm serves more than 400 companies worldwide and is particularly relevant to the energy industry for integrating and using renewable energies. Meteomatics also produces the world's first autonomous weather drones ('Meteodrones') that collect atmospheric data up to 6 km to improve local forecast quality. The company raised 13.5M CHF in a Series B financing round to support its growth. Klima Energy Transition Fund (Alantra) led the round in partnership with Spanish gas grid operator Enagás, and the round was completed by a leading US-based renewables and utility company. Management and investors say the proceeds will be used to further develop technology, provide higher-value services, and expand into new segments and geographies. Meteomatics develops weather forecasts for corporate clients by combining conventional meteorological data with frequent drone measurements of the near-surface atmosphere. Its drones ascend multiple times per day up to three kilometers to record wind speed, temperature and humidity. The company has developed a weather drone capable of automated takeoff and landing and operates automated drone boxes that can be centrally controlled. Customers include firms in the automotive, logistics, retail and energy sectors, notably SBB, Alpiq, Swissgrid and BKW. Founded in 2012 and led by CEO Martin Fengler, Meteomatics employs 25 people and is profitable. To accelerate growth the company completed its first financing round last autumn and plans to expand its drone network from northeastern Switzerland to the rest of the country.

Participated · Seed · May 2023

Gossik launched its digital productivity assistant in app stores at the end of 2021 and attracted users in Europe, the U.S. and Australia. During a financing round last year the founders refocused the product specifically on people with ADHD after receiving extensive feedback and improvement requests from that user group. The company is concentrating its offering on children and adolescents to help them maintain daily structure and to relieve parents. Gossik employs experienced ADHD specialists who support both customer care and product development. The startup has a waiting list for its accompanying coaching offering. Fresh capital raised will be used to further develop the assistant, improve scalability and expand the support/coaching services. Gossik builds a personal assistant app that learns when users can and want to complete tasks and integrates those tasks into daily plans. Founded by Benno Staub and Diego Gladig after their master's degrees in summer 2019, the startup is based in the St. Gallen region. The app moved from German to English and is currently in a beta test with mainly international testers; the founders plan a public App Store launch by year-end. The four-person team plans to reinvest new funds into product development and expand the development team in autumn. The company recently closed a six-figure financing round to accelerate development and prepare for a broader rollout.

Participated · Seed · Sep 2022

matriq is a St. Gallen spinoff from the Ostschweizer Fachhochschule (OST) that develops in-mold marking and coding technologies for plastic parts. Its patented DynamicMold technology already markets date- and time-stamping of parts. In Q1 2024 the company plans to launch the DM-qode, which applies a unique, continuously changing code to parts. That code can include origin and process data, serial numbers, and downstream product information to enable full traceability of each plastic part. The technology targets industries such as medical devices, automotive, and consumer goods where part marking is increasingly important. The company has secured fresh capital in an extended late-seed financing to support product rollout and commercialization. Matriq, founded in 2019 as a spinoff from OST Ostschweizer Fachhochschule, has developed a unique watermark for plastics to provide identity, traceability and brand trust for MedTech, automotive and industrial applications. Its technology individually marks plastic parts with a camera‑readable 2D code directly in forming processes such as injection moulding. DM‑date, launched earlier this year, is the world’s first digital date‑and‑time stamp for injection moulding and uses a tiny mould insert to mark each part with the exact manufacturing time and date. The company has begun implementing its DynamicMold technology with customers in Switzerland, Germany, Austria and Italy and plans to advance the flagship product further. Matriq will use the fresh capital to develop the product and expand its sales and service organization across Europe and the USA. The article highlights a large addressable market: over 14,000 European plastics manufacturers with around 200,000 installed machines, representing roughly 35% of the EUR 280 billion global injection‑moulding market. Matriq is a St. Gallen–based startup that develops patented marking and security solutions to embed machine‑readable 2D codes into plastic parts during production. Its technology leaves an individual 2D code within milliseconds while the part is being produced; the code is visible to the eye, readable by code readers or smartphone cameras, and includes optical security structures to make copying difficult. The solution works in injection molding, blow molding, thermoforming and hot stamping and can be integrated into the production machine (in‑mold), avoiding additional external equipment. Integration with company software supports assignment of necessary parameters for traceability and automation. Target applications include medical devices, automotive and other industries, and the target market for individual traceability marking is estimated at €7 billion. Founders are André Bernard (CEO), Klaus Dietrich (CTO), Cornelia Nef and Mathias Mächler; Matriq plans to use recent funds to strengthen its sales team and equip customer implementation projects with its first digital date stamp for plastics. Matriq AG is an NTB spin-off based in St. Gallen that develops marking and security solutions for plastics using its DynamicMold technology. The technology embeds a 2D-code watermark into parts during the molding process, creating a unique device identity without delaying cycle times. Its first product, the DM-date digital date stamp for injection molding, was scheduled to launch in 4Q2020. The company was founded in October 2019 by four engineers/scientists from the University of Applied Sciences Buchs NTB and spun off with initial capital of 200 kCHF. As of the press release the team had seven members and was hosted in the Startfeld innovation center. In July 2020 it installed a new board of directors including Martin Angehrn as chairman. Matriq raised CHF 1.75M in an oversubscribed Series A in 2020.

Led · Seed · Aug 2022

Aseptuva is a Swiss-UK MedTech startup developing an optomechanical device intended to prevent hospital-acquired infections, which affect over 4.4M patients in Europe each year and cause about 40,000 deaths. The company focuses on preventing bacterial colonization of catheter surfaces that can lead to lethal bloodstream infections and aims to transform intensive care medicine globally. Aseptuva was selected by the European MedPhab programme and will collaborate with Philips Innovation Services and the Tyndall National Institute to bring its device closer to market readiness. The MedPhab-supported project focuses on photonics-based diagnostic and treatment instrumentation and will help scale the company from product development to a near market-ready device using advanced manufacturing methods, quality assurance, and precision engineering. The project runs until mid-2024 and involves photonics, microbiology, and regenerative tissue engineering, which the team expects will expand its interdisciplinary capabilities. MedPhab support (worth up to EUR 200,000) has also helped convince new investors and existing shareholders to join a recently launched seed round; the company says it is talking with further investors to close the round. Aseptuva is developing a novel disinfection technology that uses non-harmful UVC illumination on skin to prevent infections associated with central venous catheters. The company targets hospital-acquired infections (HAI), citing more than 350,000 such infections annually in the US and Europe, over 40,000 related deaths, and CHF 9 billion in healthcare costs. Aseptuva positions its technology as an additional defense against antimicrobial resistance (AMR), referencing WHO projections about AMR’s future mortality impact. The three co-founders met in 2019, filed initial patents, validated a proof-of-concept, and incorporated first as a GmbH before transforming into an AG. The startup is based at Technopark Winterthur and has received support from medical doctors and entrepreneurial competitions. With the new funding, it plans to accelerate R&D, prototyping and clinical research, grow the team, and set up subsidiaries abroad near research partners.